Related Experiment Videos
Lipids, lipoproteins and coronary heart disease in minority populations
1Department of Medicine, Morehouse School of Medicine, Atlanta, GA 30310-1495.
Insights
Cardiovascular disease (CVD) risk factors vary across minority populations. Understanding these lipid differences is key to reducing CVD mortality in diverse groups.
Area of Science:
- Epidemiology
- Cardiovascular Health
- Health Disparities
Background:
- Cardiovascular disease (CVD) is a leading cause of death in the US, with risk factors identified by studies like the Framingham Study, which had limited minority inclusion.
- Lipid abnormalities are significant, yet understudied, risk factors for coronary heart disease (CHD) within minority populations.
- Existing research indicates variations in lipid profiles and CVD outcomes among different racial and ethnic groups, including Black, Hispanic, and Native American populations.
Purpose of the Study:
- To investigate the association between lipid abnormalities and cardiovascular disease (CVD) risk in various minority populations.
- To explore how differences in lipid profiles (e.g., HDL, LDL, Lipoprotein(a)) may explain observed variations in CVD mortality rates among racial groups.
- To highlight the need for understanding epidemiologic and pathophysiologic data specific to minority groups to reduce CVD morbidity and mortality.
Main Methods:
- Review of existing epidemiologic and pathophysiologic data on lipid profiles and CVD risk in minority populations.
- Analysis of studies examining total cholesterol, HDL cholesterol, LDL cholesterol, and Lipoprotein(a) in relation to CHD risk across different racial groups.
- Comparative analysis of CVD mortality rates and associated risk factors in Hispanic and Native American populations versus the general population.
Main Results:
- Total cholesterol is a predictor of CHD risk in Black men.
- Black men and women generally exhibit higher HDL cholesterol levels compared to white individuals, potentially explaining lower CHD mortality.
- Black individuals have significantly higher Lipoprotein(a) levels, an independent CHD risk factor. Hispanics show lower CVD mortality despite risk factors like obesity and diabetes. Native Americans have lower CHD prevalence linked to favorable lipid profiles (lower LDL, higher HDL).
Conclusions:
- Significant disparities exist in lipid profiles and CVD risk across racial and ethnic minority groups.
- Understanding these population-specific differences in lipid metabolism and CVD association is crucial for targeted prevention and treatment strategies.
- Further research into the epidemiologic and pathophysiologic nuances of CVD in minorities is essential for reducing health disparities and improving outcomes.
Abstract:
Despite recent advances in both prevention and treatment, cardiovascular disease (CVD) remains the leading cause of mortality in the US. The Framingham Study was a landmark in defining CHD-related risk factors; unfortunately, very few minorities were included. A major preventable risk factor for CHD continues to be lipid abnormalities, but its association within minority populations is unclear. The few studies that have examined the association of hyperlipidemia with CHD in minorities have shown that total cholesterol was a predictor of CHD risk (e.g., black men aged 35-64). Several researchers have reported higher levels of HDL for black men and women compared to white men and women. Since HDL was shown to be inversely related to CHD, this discrepancy in HDL is hypothesized to account for the lower than expected mortality rate. Lipoprotein(a) has been identified as an independent risk factor for CHD; blacks have considerably higher levels than whites. Data also indicate the following: Hispanics have lower CVD mortality rates than the general population despite having known risk factors (e.g., obesity, diabetes, low socioeconomic status); Hispanic women have lower levels of HDL cholesterol; Native-American populations have lower prevalence of CHD associated with lower LDL-cholesterol and higher HDL-cholesterol. Understanding epidemiologic and pathophysiologic data regarding differences between various racial groups should help reduce CVD-related morbidity and mortality in minority populations.